Immunome (IMNM) EV/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
EV/EBITDA | ? | 0.20 | 0.52 | -4.07 | -0.19 | -0.70 | 1.19 | |
Changes by years, y/y, % | +243% | +154% | -888% | -95% | +273% |
Immunome. EV/EBITDA
Immunome. EV/EBITDA, changes, %
Immunome (IMNM) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EV/EBITDA | ? | -0.57 | -2.25 | -0.52 | -0.90 | 0.23 | 1.19 | |
Changes by years, y/y, % | -30% | +1 685% | -29% | +389% | -140% | |||
Changes by quarters, q/q, % | +208% | +296% | -77% | +73% | -125% |